United StatesSertraline Hydrochloride Tablets USP, 100 mg, 90‑tablet bottles (NDC 68180‑353‑09) manufactured by Lupin Pharmaceuticals, lot QB00865, exp Feb 2028, is being recalled. The recall is nationwide and ongoing due to a defective container seal that is not adhering to bottles.
What's being recalled
Sertraline Hydrochloride Tablets USP, 100 mg, 90 Tablets bottles, Rx Only, Manufactured by: Lupin Pharmaceuticals, Inc., Naples, FL 34108, NDC 68180-353-09.
Recalling firm: Lupin Pharmaceuticals Inc., Naples, FL, United States.
How to identify it
Lot # QB00865, exp. date Feb 2028
The hazard
Defective container - seal not adhering to bottles
What to do
Don't stop taking a prescribed medicine without talking to your doctor or pharmacist first. For other products, stop using them and ask the pharmacist, seller or maker what to do.
The notice doesn't give instructions for consumers, so this is general advice for health & beauty recalls. Check the official notice for the details.
Where it was sold
Nationwide.
The official notice
This page is a summary of the notice published by U.S. Food and Drug Administration (enforcement reports), collected from U.S. Food and Drug Administration (enforcement reports). Check the original before you act on it.
Read the official notice (opens in a new tab)